Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging

While many age-associated immune changes have been reported, a comprehensive set of metrics of immune aging is lacking. Here we report data from 243 healthy adults aged 40–97, for whom we measured clinical and functional parameters, serum cytokines, cytokines and gene expression in stimulated and unstimulated PBMC, PBMC phenotypes, and cytokine-stimulated pSTAT signaling in whole blood. Although highly heterogeneous across individuals, many of these assays revealed trends by age, sex, and CMV status, to greater or lesser degrees. Age, then sex and CMV status, showed the greatest impact on the immune system, as measured by the percentage of assay readouts with significant differences. An elastic net regression model could optimally predict age with 14 analytes from different assays. This reinforces the importance of multivariate analysis for defining a healthy immune system. These data provide a reference for others measuring immune parameters in older people.

[1]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  Holden T Maecker,et al.  Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. , 2002, The Journal of infectious diseases.

[3]  I. Weissman,et al.  Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion , 2010, Proceedings of the National Academy of Sciences.

[4]  F. Miedema,et al.  Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. , 2012, Immunity.

[5]  Atul J. Butte,et al.  Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences , 2015, Cell.

[6]  P. Araoz,et al.  Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans. , 2008, Gender medicine.

[7]  C. Weyand,et al.  Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age , 2012, Proceedings of the National Academy of Sciences.

[8]  G. Pawelec,et al.  Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. , 2009, Current opinion in immunology.

[9]  Mary M. Cavanagh,et al.  Finding Balance: T cell Regulatory Receptor Expression during Aging. , 2011, Aging and disease.

[10]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.

[11]  P. Moss,et al.  Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.

[12]  R. Shephard,et al.  A simple method to assess exercise behavior in the community. , 1969, Canadian journal of applied sport sciences. Journal canadien des sciences appliquees au sport.

[13]  I. Bartenjev,et al.  Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients , 2011, Melanoma research.

[14]  C. Ling,et al.  Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  G. Kelsoe,et al.  Ig VH hypermutation is absent in the germinal centers of aged mice. , 1995, Journal of immunology.

[16]  A. Lång,et al.  Functional CD8 T Cell Memory Responding to Persistent Latent Infection Is Maintained for Life , 2011, The Journal of Immunology.

[17]  C. Bouchard,et al.  Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease , 1997, Diabetologia.

[18]  N. Weng,et al.  CD28(-) T cells: their role in the age-associated decline of immune function. , 2009, Trends in immunology.

[19]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[20]  Debashis Sahoo,et al.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age , 2011, Proceedings of the National Academy of Sciences.

[21]  Steven G. Deeks,et al.  Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging , 2014, PloS one.

[22]  Sarah E. Jackson,et al.  Cytomegalovirus Infection Reduces Telomere Length of the Circulating T Cell Pool , 2010, The Journal of Immunology.

[23]  Mark M. Davis,et al.  Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires , 2014, The Journal of Immunology.

[24]  F. Marincola,et al.  High-dimensional analysis of the aging immune system: Verification of age-associated differences in immune signaling responses in healthy donors , 2014, Journal of Translational Medicine.

[25]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[26]  J. Cambier,et al.  Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging , 2008, Proceedings of the National Academy of Sciences.

[27]  S. Fischer,et al.  Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness , 2009, Journal of Virology.

[28]  Jeffrey N. Martin,et al.  IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells , 2006, AIDS research and therapy.

[29]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[30]  C. Weyand,et al.  Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.

[31]  J. Cerny,et al.  Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice , 1996, The Journal of experimental medicine.

[32]  J. Coebergh,et al.  Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.